Laurus Labs Ltd. shares jumped by up to 10 per cent on Thursday, January 30, following the U.S. approval of an "emergency humanitarian waiver" that ensures continued access to U.S.-funded HIV ...

Furthermore, Laurus Labs projects that its fiscal year 2026 estimates, particularly in the Contract Development and Manufacturing Organization (CDMO) segment, will surpass those of fiscal year 2025.

Laurus Labs to invest ₹83.30 crore in joint venture with KRKA for new manufacturing facility and market expansion.

Hyderabad: Laurus Labs has announced that the Company has approved an investment of Rs 83 crore in KRKA Pharma, a joint ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Laurus Labs Ltd is quoting at Rs 564.2, up 3.43% on the day as on 12:49 IST on the NSE. The stock is up 37.39% in last one year as compared to a 0.46% fall in NIFTY and a 4.57% fall in the Nifty ...

The said transaction falls under related party transactions. However, the same is being carried at arm’s length price.

Stocks to Watch, Mar 7: Stocks like Tamilnad Mercantile Bank, NMDC, Jindal Stainless, Sudarshan Pharma Industries, Brigade Enterprises, Rail Vikas Nigam, RITES, Laurus Labs, Bharat Electronics ...

The pharma sector export data for fourth quarter has been released. According to Phillip Capital, the latest export data ...

Laurus Labs Ltd share price was down by -1.76% from the previous closing price of ₹584.35. Who are peers of Laurus Labs Ltd? The peers of Laurus Labs Ltd are Sun Pharmaceuticals Industries Ltd ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...